Financials

  • Market Capitalization 15.3 M
  • Employee 18
  • Founded 2017
  • CEO N/A
  • Website vyometx.com
  • Headquarter Delaware, United States
  • FIGI BBG0036S6JY0
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.71
Fiyat/satışlar oranı
23.26

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
4697
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.85 USD-0.77%+10.63%+16.31%+18.46%16.67 M USD
4704
AKTX
Akari Therapeutics Plc - American Depositary Shares
13.19 USD-1.57%-14.79%-1.93%+1088.29%15.10 M USD
4711
QNCX
Quince Therapeutics, Inc. - Common Stock
19.98 USD+15.83%+12.63%+2048.39%+1003.87%16.28 M USD
4722
LEXX
Lexaria Bioscience Corp. - Common Stock
0.59 USD0.00%+7.27%-1.67%-29.76%14.62 M USD